Health Care: Drugs

Oncolytics Biotech Inc (ONCY: NASDAQ)

$1 0.18 | 21.95%
10/31/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 0.82
52 Week High 2.70
52 Week Low 0.40
Avg. Daily Vol. (Mil) 0.44
Beta (3 year) 1.56
Share Related Items
Mkt Cap (Mil) 71.78
Shares Out (Mil) 87.54
Float (Mil) 83.62
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 5.20
Current Ratio 5.30
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.00
Price/Book 4.68
Price/Cash Flow -3.60
Per Share Data
Earnings -0.24
Sales 0.00
Book Value 0.18
Cash Flow -0.23
Business Summary
Oncolytics Biotech, Inc., is a development stage biopharmaceutical company that focuses on the discovery and development of pharmaceutical products for the treatment of cancers.
General Information
210, 1167 Kensington Crescen
Calgary, AB T2N 1X7
www.oncolyticsbiotech.com
Industry : Drugs
Sector: Health Care
Employees: 25
CEO: Dr. Bradley G. Thompson,
Short Interest
Current Month (Mil) 0.70
Previous Month (Mil) 0.86
Short Interest Ratio (Days) 1.00
Management Effectiveness
Return on Equity n.a.
Return on Assets -107.60
Return on Investments -131.70
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with ONCY

Latest ONCY Headlines from TheStreet

More Financial News for ONCY

Press Releases for ONCY

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter